Journal
CURRENT OPINION IN PHARMACOLOGY
Volume 2, Issue 1, Pages 99-103Publisher
ELSEVIER SCI LTD
DOI: 10.1016/S1471-4892(01)00128-X
Keywords
-
Categories
Ask authors/readers for more resources
Despite evidence from a variety of experimental approaches implicating the neuropeptide neurotensin in both the mechanism of action of antipsychotic drugs and the pathophysiology of schizophrenia, there has been some debate as to whether a peripherally administered neurotensin receptor agonist represents a sound strategy for the development of a novel class of antipsychotic drugs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available